These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7139336)

  • 1. Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbits.
    Eva C; Blengio M; Ferretti C; Muccioli G; Portaleone P
    Brain Res; 1982 Nov; 251(2):388-90. PubMed ID: 7139336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG; Sinha YN; Finch CE
    Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
    Cronin MJ; Reches A; MacLeod RM; Login IS
    Eur J Pharmacol; 1983 Jul; 91(2-3):229-34. PubMed ID: 6617744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors.
    Palacios JM; Niehoff DL; Kuhar MJ
    Brain Res; 1981 Jun; 213(2):277-89. PubMed ID: 7248759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 9. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
    Beart PM; Krstich M; McDonald D; Gundlach AL
    Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic proglumide increases [3H]spiperone binding in the rat brain.
    Bean AJ; Baldy WJ; Martin GE
    Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
    Agnati LF; Fuxe K; Battistini N; Benfenati F
    Acta Physiol Scand; 1984 Mar; 120(3):465-7. PubMed ID: 6331074
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat.
    Simpson MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1986 Oct; 35(19):3203-8. PubMed ID: 3768017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol.
    Bischoff S
    Experientia; 1981; 37(9):1008-9. PubMed ID: 7297644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K; Sato M; Otsuki S
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3H-Spiroperidol binding to striatal membranes of mutant Han-Wistar rats which exhibit spastic paresis.
    Golombiowska-Nikitin K; Sontag KH; Osborne NN
    Experientia; 1981 May; 37(5):490-1. PubMed ID: 7250319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic sulpiride on striatal spiperone binding.
    Bannet J; Gillis S; Ebstein RP; Belmaker RH
    Int Pharmacopsychiatry; 1980; 15(6):334-7. PubMed ID: 7298264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.